NGAL is an early biomarker for detecting kidney disease, especially acute kidney injury (AKI). Used for auxiliary diagnosis of renal tubular injury.
2025-03-02This product is used for the in vitro quantitative detection of β2-microglobulin levels in human urine samples. Clinically, it is primarily used for monitoring the function of proximal renal tubules.
2025-03-02Used for in vitro quantitative detection of the content of neutrophil gelatinase-associated lipocalin in human urine.
2025-03-21Serum amyloid A (SAA)/C-reactive protein (CRP) detection kit (fluorescence immunoassay)
2025-03-21used for in vitro quantitative detection of the content of glycated hemoglobin (HbA1c) in human whole blood.
2025-03-21